Ganaxolone formulations and methods for the making and use thereof

Details for Australian Patent Application No. 2006318349 (hide)

Owner Marinus Pharmaceuticals

Inventors Shaw, Kenneth; Zhang, Mingbao

Agent Wrays

Pub. Number AU-B-2006318349

PCT Pub. Number WO2007/062266

Priority 60/740,208 28.11.05 US; 60/740,174 28.11.05 US; 60/758,171 11.01.06 US

Filing date 28 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 19 August 2010

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/062266 Priority application(s): WO2007/062266

10 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Jun 2008

19 August 2010 Application Accepted

  Published as AU-B-2006318349

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318352-Blood monitoring system

2006318348-Processes for filming biodegradable or compostable containers